CIPLA LINEZOLID linezolid 600 mg film-coated tablet blister pack

Land: Australia

Språk: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv ingrediens:

linezolid, Quantity: 600 mg

Tilgjengelig fra:

Cipla Australia Pty Ltd

INN (International Name):

Linezolid

Legemiddelform:

Tablet, film coated

Sammensetning:

Excipient Ingredients: magnesium stearate; hyprolose; sodium starch glycollate type A; microcrystalline cellulose; maize starch; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3000

Administreringsrute:

Oral

Enheter i pakken:

30, 10

Resept typen:

(S4) Prescription Only Medicine

Indikasjoner:

CIPLA LINEZOLID is indicated for the treatment of suspected or proven infections due to Gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant Staphylococcus species and vancomycin resistant Enterococcus species.,CIPLA LINEZOLID is active against Gram-positive bacteria only. ,CIPLA LINEZOLID has no clinical activity against Gram-negative pathogens. Specific Gram-negative therapy is required if a concomitant Gram- negative pathogen is documented or suspected.

Produkt oppsummering:

Visual Identification: White to off-white, oval shaped, biconvex, film-coated tablets, debossed on one side "CL".; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Autorisasjon status:

Licence status A

Autorisasjon dato:

2017-01-24